Long Non-Coding RNA (lncRNA) Signaling in Neurodegeneration
Overview
Long non-coding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides that do not code for proteins but regulate gene expression through diverse mechanisms. Once considered "genomic noise," lncRNAs have emerged as critical regulators of neuronal development, synaptic plasticity, and neurodegeneration. Dysregulation of lncRNAs contributes to the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (FTD), Huntington's disease (HD), and other neurodegenerative disorders. [@riva2023]
This pathway page covers the major lncRNAs implicated in neurodegeneration, their molecular mechanisms, and therapeutic targeting strategies. [@khalil2022]
Key lncRNA Classes in Neurodegeneration
Nuclear lncRNAs
Nuclear lncRNAs primarily regulate gene transcription through chromatin remodeling and transcriptional interference. [@zhang2024]
...
Long Non-Coding RNA (lncRNA) Signaling in Neurodegeneration
Overview
Long non-coding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides that do not code for proteins but regulate gene expression through diverse mechanisms. Once considered "genomic noise," lncRNAs have emerged as critical regulators of neuronal development, synaptic plasticity, and neurodegeneration. Dysregulation of lncRNAs contributes to the pathogenesis of Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (FTD), Huntington's disease (HD), and other neurodegenerative disorders. [@riva2023]
This pathway page covers the major lncRNAs implicated in neurodegeneration, their molecular mechanisms, and therapeutic targeting strategies. [@khalil2022]
Key lncRNA Classes in Neurodegeneration
Nuclear lncRNAs
Nuclear lncRNAs primarily regulate gene transcription through chromatin remodeling and transcriptional interference. [@zhang2024]
NEAT1 (Nuclear Enriched Abundant Transcript 1): Forms nuclear paraspeckles, regulates gene expression by sequestering transcription factors. Upregulated in AD and ALS, involved in DNA damage response and stress granule dynamics.
MALAT1 (Metastasis Associated Lung Adenocarcinoma Transcript 1): Regulates synaptic plasticity, alternative splicing, and neuronal differentiation. Dysregulated in AD (affecting APP processing) and PD.
XIST (X-inactive specific transcript): Regulates X-chromosome inactivation. May contribute to sex-biased neurodegeneration patterns.
HOTAIR (HOX Transcript Antisense RNA): Regulates HOX gene clusters, promotes chromatin silencing. Elevated in AD brains, affects [tau](/proteins/tau) pathology.
MEG3 (Maternally Expressed Gene 3): Tumor suppressor lncRNA with neuroprotective properties. Reduced in AD and PD.
Cytoplasmic lncRNAs
Cytoplasmic lncRNAs regulate mRNA stability, translation, and protein function. [@johnson2023]
BC200 (Brain Cytoplasmic RNA 200): Regulates dendritic translation at synapses. Overexpressed in AD, correlates with cognitive decline.
AS UCHL1: Antisense transcript of ubiquitin C-terminal hydrolase L1, regulates PARK5 gene. Implicated in PD.
lncRNAs in Alzheimer's Disease
Amyloid Pathology
BACE1-AS: The most well-characterized AD-related lncRNA. BACE1-AS enhances BACE1 mRNA stability, increasing [beta-secretase](/entities/bace1) activity and amyloid-beta production. Knockdown reduces amyloid burden in mouse models.
APP-AS: Antisense transcript of APP gene. Regulates APP processing and may influence amyloidogenesis.
lncRNA-171F: Regulates [amyloid precursor protein](/entities/app-protein) processing through unknown mechanisms.
Tau Pathology
HOTAIR: Elevated in AD brain, promotes tau hyperphosphorylation through epigenetic mechanisms.
NEAT1: Paraspeckle formation affected in AD, influences tau pathology progression.
LINC00672: Reduced in AD, associated with tau phosphorylation.
Synaptic Dysfunction
BC200: Overexpressed in AD temporal lobe, reduces local translation at [dendritic spines](/cell-types/dendritic-spines).
MALAT1: Regulates synapse-related gene expression, altered in AD.
lncRNA-NEAT1: Affects synaptic protein synthesis.
lncRNAs in Parkinson's Disease
Alpha-Synuclein Regulation
AS_SNCA: Antisense transcript of SNCA ([alpha-synuclein](/proteins/alpha-synuclein) gene). Regulates SNCA expression, contribute to Lewy body formation.
HOTAIR: Elevated in PD substantia nigra, affects dopaminergic neuron survival.
MEG3: Reduced in PD, associated with increased neuronal [apoptosis](/entities/apoptosis).
Mitochondrial Dysfunction
LINC00341: Regulates mitochondrial dynamics, altered in PD.
lncRNA-ATB: Regulates [autophagy](/entities/autophagy) and mitophagy, relevant to PD pathology.
Neuroinflammation
NEAT1: Promotes neuroinflammation in PD through [NF-κB](/entities/nf-kb) signaling.
MALAT1: Regulates microglial activation and inflammatory responses.
lncRNAs in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
TDP-43 Pathology
NEAT1: Essential for paraspeckle formation, altered in ALS/FTD with [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology.
TARDP-1: [C9orf72](/entities/c9orf72) antisense transcript, contributes to toxic dipeptide repeat protein production.
C9orf72 Expansion
C9orf72-AS (antisense): Bidirectional transcription produces toxic repeat RNAs and proteins.
lncRNA-EPF: Regulates ellipsoid body formation, implicated in Drosophila ALS models.
RNA Metabolism
MALAT1: Altered splicing regulation in ALS motor [neurons](/entities/neurons).
XIST: Dysregulated in female ALS patients (X-chromosome linked vulnerability).